Stay updated on AGN-150998 in AMD Clinical Trial

Sign up to get notified when there's something new on the AGN-150998 in AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AGN-150998 in AMD Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now displays the completed Phase 2 study record evaluating AGN-150998 and ranibizumab for exudative age-related macular degeneration, including its design, outcomes, eligibility criteria, and study locations.
    Difference
    58%
    Check dated 2026-11-08T14:07:58.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:38:03.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The clinical trial record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-25T15:27:56.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision number was updated from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:05:17.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T21:49:42.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating access to the study record is blocked. The new content includes a minimal header and a Home button, plus a revision banner (Revision: v3.7.0), reflecting a site-wide template update rather than substantive study data.
    Difference
    19%
    Check dated 2026-09-20T20:28:46.000Z thumbnail image

Stay in the know with updates to AGN-150998 in AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AGN-150998 in AMD Clinical Trial page.